C-Circle – Doing Business in China – Prospering During a Time of Tension and Turmoil

Date: Thursday, September 26, 2019
Time: 8:00am-10:00am
Location: Deutsche Bank Labs
Silicon Valley
2650 Birch Street
Suite 150
Palo Alto, CA 94306

Are you a CEO or other C-level executive and wish to request to be part of these events?


ACG Silicon Valley’s C-Circle, now in its ninth year, proudly announces that it has attracted a following of approximately 400 CEOs and C-level executives and achieved a regular attendance of 35 executives per session.


Doing Business in China – Prospering During a Time of Tension and Turmoil

China is undergoing massive political, economic and social changes including the transformation from an manufacturing and export economy to a service, knowledge and consumer economy. On top of this transition, China is experiencing a time of currency restrictions, social scoring, arbitrary arrests and detentions, political strife in Hong Kong, a resurgence of the Communist Party and its oversight of the business community, a trade war and escalating political rhetoric with the US. In this fast changing and tumultuous environment, can US companies doing business in China be successful?

Please join our stimulating discussion on doing business in China in 2019. Among other issues, our experts will discuss:

  • Prior to the trade war, were China’s rising labor and other costs causing US companies to look for other markets for manufacturing?
  • How have US companies been dealing with IP theft in China over the past several years?
  • How have recent US-China trade tensions impacted US companies desire to maintain or expand operations in China?
  • How important is China as a consumer market for US companies?
  • Have the views of Chinese consumers towards US brands been impacted by the trade tensions?
  • Do US companies need a presence in China to tap into this market?
  • Is China experiencing the movement of supply chains out of China?
  • To what extent?
  • Has there been a decrease in US demand for Chinese goods?
  • With respect to US companies doing business in China, what are the current obstacles they are facing?
  • Is the Chinese Government retaliating against US companies in China?
  • How does this retaliation manifest itself?
  • Are US companies in China experiencing more government investigations, negative press, slower customs approvals and suspension of permits?
  • Are personal relationships with Chinese Government officials still critical to success in China?
  • How have trade tensions impacted the ability to create these relationships?
  • How does one build trust among government officials and the business community in China?
  • Undoubtably the trade war and other events going on in China have caused political and economic uncertainty, how has this effected US companies in China?
  • Does the Chinese Government still favor domestic enterprises?
  • How does this work in practice?
  • After the arrest of the Huawei CFO in Canada, are American executives in China at risk?
  • How should US companies prepare themselves to respond to crisis in China?


Guest Experts


Fei Shen

Co-founder & Chairman

Fei Chen is Co-founder and Chairman of the Board of SemeaTech, which designs and manufactures gas and radiation sensors, sensor modules and sensor networks. As a global high tech execuive, Fei Chen specializes in operating management, strategic planning, international budgeting, finance and accounting, mergers and acquisitions.

Prior to SemeaTech, Fei Chen was Vice President, WW Manufacturing, Manufacturing Engineering and Corporate Development at RAE Systems by Honeywell. He additionally served as General Manager, RAE Systems China Operations. Prior to RAE Systems being acquired by Honeywell, Fei Chen developed organizational infrastructure and manufacturing capacity in China.

Fei Chen received Global Most Valuable Principal recognition in 2013 when working at Honeywell. He received his M.S. in mechanical engineering at University of Idaho and is a graduate, AeA of the Stanford Executive Program.


Brent Carlson


Brent is a director in the investigations, disputes, and risk practice at AlixPartners where he helps companies and their stakeholders in the areas of regulatory compliance, corporate investigations, fraud and corruption detection and prevention, dispute consulting, mergers and acquisitions, restructuring, and interim management roles.

Brent has more than 20 years of hands-on business experience that includes senior management positions for multinationals in Asia as chief representative, chief operating officer, deputy general manager, head of sales and business development, and chief compliance officer. Brent is fluent in Mandarin Chinese.
His experience includes helping companies globally with anti-fraud, anti-corruption, and trade sanction/export controls matters involving due diligence, compliance program assessments, as well as the development and implementation of effective compliance programs. He also has served in interim monitoring roles.

As a Certified Fraud Examiner, Brent has provided investigative and consulting services in corporate investigations as well as in disputes involving mediation, international arbitration, and litigation. Brent has served as an expert witness in fraud-related matters, including criminal prosecution and M&A disputes.


James C. Chapman


Jim is a partner at Rimon P.C. where he focuses his practice on securities law, venture capital, mergers and acquisitions, and international business transactions. He counsels publicly traded and privately held clients on public offerings, private placements, debt financings, venture capital transactions, mergers and acquisitions, and related transactions. Jim also represents venture capital firms, angels, and family offices in their investments. With 30 years of experience in corporate and securities law, he has represented clients in over 300 mergers, acquisitions, and financing transactions.

Although he has been involved in transactions all over the world, Jim was also an early pioneer in representing companies in cross border transactions between the US and China. These transactions include both assisting Chinese companies investing and raising capital in the U.S. and helping U.S. enterprises acquire Chinese companies, transfer technology, enter into joint ventures and operate, in China. Jim has also been involved in negotiating resolutions to some of the most high-profile disputes involving US companies operating in China.

Jim’s US-China experience extends to a wide variety of industries including media, mobile, software, semiconductor, alternative energy, nanotechnology and pharmaceuticals. He has been recognized by Finance Monthly Global Awards, ACQ5 Global Awards and Corporate Live Wire as “China Investment Attorney of the Year” for 2015, 2016 and 2017 and by Corporate Intl Legal Awards and Global Law Experts as “China Investment Attorney of the Year- California” for 2015 and 2016. Prior to joining Rimon P.C, Jim was a partner with Morgan Lewis & Bockius LLP, a leading international law firm.